{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:54:27Z","timestamp":1776315267448,"version":"3.50.1"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Adoptive T cell therapy (ACT) is a potent strategy in cancer immunotherapy, but its clinical efficacy is often limited by primary resistance. To overcome this challenge, high-throughput screening technologies have emerged as essential tools for optimizing ACT. By enabling the identification of biologically significant targets and substances from vast libraries, these technologies have accelerated the development of advanced ACT strategies. This review delves into the latest advancements in high-throughput screening, highlighting its applications in genetic screening of T cells and tumor cells, as well as non-genetic screening for small molecules and targeted delivery systems. These insights provide valuable guidance for future research and clinical applications of ACT.<\/jats:p>","DOI":"10.3389\/fonc.2026.1787786","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:20:56Z","timestamp":1776313256000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High-throughput screening to engineer optimal T cell therapies: current knowledge and future prospects"],"prefix":"10.3389","volume":"16","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Fuyang Hospital of Traditional Chinese Medicine","place":["Fuyang, China"]},{"name":"Department of General Surgery, Taihe Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine","place":["Fuyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saisai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Ding","sequence":"additional","affiliation":[{"name":"Graduate School, Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Duan","sequence":"additional","affiliation":[{"name":"Graduate School, Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Pu","sequence":"additional","affiliation":[{"name":"Graduate School, Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School, Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsheng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine","place":["Hefei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"108631","DOI":"10.1016\/j.pharmthera.2024.108631","article-title":"Orthotopic and metastatic tumour models in preclinical cancer research","volume":"257","author":"Stribbling","year":"2024","journal-title":"Pharmacol Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"011304","DOI":"10.1063\/5.0166848","article-title":"Mechanical forces amplify TCR mechanotransduction in T cell activation and function","volume":"11","author":"Jeffreys","year":"2024","journal-title":"Appl Phys Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T cells for solid tumors: New strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T cell therapy in solid tumors: State of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci Adv"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116409","article-title":"Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma","volume":"173","author":"Huang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.11.009","article-title":"Tumor immunology CRISPR screening: present, past, and future","volume":"8","author":"Dong","year":"2022","journal-title":"Trends Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104287","article-title":"Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies","volume":"196","author":"Quintero-Ruiz","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188378","article-title":"CRISPR screen in mechanism and target discovery for cancer immunotherapy","volume":"1874","author":"Liu","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2020.03.039","article-title":"Pooled knockin targeting for genome engineering of cellular immunotherapies","volume":"181","author":"Roth","year":"2020","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04494-7","article-title":"A genome-scale screen for synthetic drivers of T cell proliferation","volume":"603","author":"Legut","year":"2022","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204484","article-title":"Massively parallel CRISPR-based genetic perturbation screening at single-cell resolution","volume":"10","author":"Cheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-023-01495-5","article-title":"CRISPR screening in hematology research: From bulk to single-cell level","volume":"16","author":"Meyers","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06733-x","article-title":"Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer","volume":"624","author":"Zhou","year":"2023","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj4008","article-title":"CRISPR activation and interference screens decode stimulation responses in primary human T cells","volume":"375","author":"Schmidt","year":"2022","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0392-0","article-title":"Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells","volume":"16","author":"Mimitou","year":"2019","journal-title":"Nat Methods"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01153-z","article-title":"Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing","volume":"18","author":"Datlinger","year":"2021","journal-title":"Nat Methods"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/s41467-019-10216-x","article-title":"Model-based understanding of single-cell CRISPR screening","volume":"10","author":"Duan","year":"2019","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-02017-4","article-title":"A new Bayesian factor analysis method improves detection of genes and biological processes affected by perturbations in single-cell CRISPR screening","volume":"20","author":"Zhou","year":"2023","journal-title":"Nat Methods"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115198","article-title":"Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy","volume":"207","author":"Silvestrini","year":"2024","journal-title":"Adv Drug Delivery Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115927","article-title":"Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery","volume":"169","author":"Hashemi","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/thno.71144","article-title":"CRISPR-Cas9 library screening approach for anti-cancer drug discovery: Overview and perspectives","volume":"12","author":"Chan","year":"2022","journal-title":"Theranostics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac458","article-title":"An in-library ligation strategy and its application in CRISPR\/Cas9 screening of high-order gRNA combinations","volume":"50","author":"Lu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: Advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06835-6","article-title":"Base-editing mutagenesis maps alleles to tune human T cell functions","volume":"625","author":"Schmidt","year":"2024","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2021.01.012","article-title":"Massively parallel assessment of human variants with base editor screens","volume":"184","author":"Hanna","year":"2021","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ccell.2022.12.009","article-title":"Base editing screens map mutations affecting interferon-\u03b3 signaling in cancer","volume":"41","author":"Coelho","year":"2023","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.03.024","article-title":"CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi","volume":"31","author":"Bendixen","year":"2023","journal-title":"Mol Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1016\/j.cell.2022.06.039","article-title":"Large-scale multiplexed mosaic CRISPR perturbation in the whole organism","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cmet.2022.02.009","article-title":"A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy","volume":"34","author":"Ye","year":"2022","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12964-024-01551-8","article-title":"The role of Bach2 in regulating CD8\u2009+\u2009T cell development and function","volume":"22","author":"Weng","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01498-x","article-title":"ST3GAL1 and \u03b2II-spectrin pathways control CAR T cell migration to target tumors","volume":"24","author":"Hong","year":"2023","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abl9169","article-title":"A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells","volume":"15","author":"Johansen","year":"2022","journal-title":"Sci Signal"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05126-w","article-title":"RASA2 ablation in T cells boosts antigen sensitivity and long-term function","volume":"609","author":"Carnevale","year":"2022","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"109516","DOI":"10.2210\/pdb8wpj\/pdb","article-title":"NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells","volume":"36","author":"Wang","year":"2021","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2020.05.004","article-title":"Multi-phenotype CRISPR-Cas9 screen identifies p38 kinase as a target for adoptive immunotherapies","volume":"37","author":"Gurusamy","year":"2020","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1801340115","article-title":"Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation","volume":"115","author":"Shang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2019.07.044","article-title":"Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells","volume":"178","author":"Dong","year":"2019","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.608484","article-title":"Single-molecule, super-resolution, and functional analysis of G protein-coupled receptor behavior within the T cell immunological synapse","volume":"8","author":"Felce","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208522119","article-title":"Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells","volume":"119","author":"Kubo","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/gad.322024.118","article-title":"The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain Cd4 silencing in cytotoxic T cells","volume":"33","author":"Ng","year":"2019","journal-title":"Genes Dev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.01.538906","article-title":"Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens","volume":"55","author":"McCutcheon","year":"2023","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2021.02.021","article-title":"In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions","volume":"184","author":"Huang","year":"2021","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04849-0","article-title":"cBAF complex components and MYC cooperate early in CD8+ T cell fate","volume":"607","author":"Guo","year":"2022","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1101\/2022.04.20.488974","article-title":"Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence","volume":"40","author":"Belk","year":"2022","journal-title":"Cancer Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade3369","article-title":"In vitro modeling of CD8+ T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40","volume":"8","author":"Wu","year":"2023","journal-title":"Sci Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.molcel.2023.02.026","article-title":"Stepwise activities of mSWI\/SNF family chromatin remodeling complexes direct T cell activation and exhaustion","volume":"83","author":"Battistello","year":"2023","journal-title":"Mol Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.027","article-title":"Blockage of core fucosylation reduces cell-surface expression of PD-1 and promotes anti-tumor immune responses of T cells","volume":"20","author":"Okada","year":"2017","journal-title":"Cell Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: Key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110177","article-title":"Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases","volume":"262","author":"Koga","year":"2024","journal-title":"Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345838","article-title":"Reprogramming of regulatory T cells in inflammatory tumor microenvironment: Can it become immunotherapy turning point","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41467-022-35583-w","article-title":"Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy","volume":"14","author":"Trefny","year":"2023","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1243","article-title":"CRISPR screening of CAR T cells and cancer stem cells reveals critical dependencies for cell-based therapies","volume":"11","author":"Wang","year":"2021","journal-title":"Cancer Discov"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn5647","article-title":"Enhanced T cell effector activity by targeting the Mediator kinase module","volume":"378","author":"Freitas","year":"2022","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01639-x","article-title":"Massively parallel knock-in engineering of human T cells","volume":"41","author":"Dai","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1101\/2022.07.27.501186","article-title":"Modular pooled discovery of synthetic knockin sequences to program durable cell therapies","volume":"186","author":"Blaeschke","year":"2023","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v128.22.2170.2170","article-title":"A rational strategy for reducing on-target off-tumor effects of CD38-chimeric antigen receptors by affinity optimization","volume":"25","author":"Drent","year":"2017","journal-title":"Mol Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003091","article-title":"Avidity-based selection of tissue-specific CAR-T cells from a combinatorial cellular library of CARs","volume":"8","author":"Ma","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.08.003","article-title":"A functional screening strategy for engineering chimeric antigen receptors with reduced on-target, off-tumor activation","volume":"28","author":"Di Roberto","year":"2020","journal-title":"Mol Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1335424","article-title":"Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic","volume":"15","author":"Smirnov","year":"2024","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1101\/2021.08.23.457342","article-title":"speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing","volume":"13","author":"Castellanos-Rueda","year":"2022","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm1463","article-title":"Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies","volume":"14","author":"Goodman","year":"2022","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00896-0","article-title":"Screening for CD19-specific chimaeric antigen receptors with enhanced signaling via a barcoded library of intracellular domains","volume":"6","author":"Gordon","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106529","article-title":"Design of diversified chimeric antigen receptors through rational module recombination","volume":"26","author":"Si","year":"2023","journal-title":"iScience"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362709","article-title":"Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions","volume":"15","author":"He","year":"2024","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of Polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2022.09.007","article-title":"Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses","volume":"40","author":"Chan","year":"2022","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0545","article-title":"Nedd4-binding protein 1 and TNFAIP3-interacting protein 1 control MHC-1 display in neuroblastoma","volume":"78","author":"Spel","year":"2018","journal-title":"Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-0812","article-title":"Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade","volume":"11","author":"Gu","year":"2021","journal-title":"Cancer Discov"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06482-x","article-title":"CRISPR screens decode cancer cell pathways that trigger \u03b3\u03b4 T cell detection","volume":"621","author":"Mamedov","year":"2023","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001346","article-title":"CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma","volume":"4","author":"Ramkumar","year":"2020","journal-title":"Blood Adv"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01314-y","article-title":"NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia","volume":"23","author":"Witkowski","year":"2022","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705260","article-title":"CD58 immunobiology at a glance","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1186\/1471-2377-14-57","article-title":"The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity","volume":"41","author":"Ho","year":"2023","journal-title":"Cancer Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1327784","article-title":"Interferon autoantibodies as signals of a sick thymus","volume":"15","author":"Oftedal","year":"2024","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-023-08975-z","article-title":"Tumor necrosis factor alpha inhibitors and cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Luciano","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12967-024-04890-9","article-title":"Exploring the role of ubiquitin regulatory X domain family proteins in cancers: bioinformatics insights, mechanisms, and implications for therapy","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153391","article-title":"HOIP limits anti-tumor immunity by protecting against combined TNF and IFN-gamma-induced apoptosis","volume":"22","author":"Freeman","year":"2021","journal-title":"EMBO Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050155","article-title":"MLLT6 maintains PD-L1 expression and mediates tumor immune resistance","volume":"21","author":"Sreevalsan","year":"2020","journal-title":"EMBO Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1038\/s41467-022-29442-x","article-title":"Ubiquitin ligase STUB1 destabilizes IFN\u03b3-receptor complex to suppress tumor IFN\u03b3 signaling","volume":"13","author":"Apriamashvili","year":"2022","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0578-8","article-title":"Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1","volume":"21","author":"Crowther","year":"2020","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212525","article-title":"A CMV-induced adaptive human V\u03b41+ \u03b3\u03b4 T cell clone recognizes HLA-DR","volume":"219","author":"Deseke","year":"2022","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111153","article-title":"Cancer genes disfavoring T cell immunity identified via integrated systems approach","volume":"40","author":"Kishton","year":"2022","journal-title":"Cell Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add0005","article-title":"Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-0584","article-title":"Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer","volume":"14","author":"Sang","year":"2024","journal-title":"Cancer Discov"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1038\/s41467-023-38841-7","article-title":"In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer","volume":"14","author":"Dervovic","year":"2023","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00251","article-title":"Genome-wide CRISPR screening identifies JAK1 deficiency as a mechanism of T-cell resistance","volume":"10","author":"Han","year":"2019","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor immune evasion arises through loss of TNF sensitivity","volume":"3","author":"Kearney","year":"2018","journal-title":"Sci Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13045-022-01389-y","article-title":"Double knockout CRISPR screen for cancer resistance to T cell cytotoxicity","volume":"15","author":"Park","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41467-020-14290-4","article-title":"Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-\u03b3-signaling mutant cancer cells","volume":"11","author":"Williams","year":"2020","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.02.018","article-title":"USP22 deficiency in melanoma mediates resistance to T cells through IFN\u03b3-JAK1-STAT1 signal axis","volume":"29","author":"Li","year":"2021","journal-title":"Mol Ther"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100655","article-title":"RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells","volume":"3","author":"Zhang","year":"2022","journal-title":"Cell Rep Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.7554\/elife.84314","article-title":"Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells","volume":"12","author":"Herzfeldt","year":"2023","journal-title":"Elife"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1038\/s41467-023-41101-3","article-title":"Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity","volume":"14","author":"Cui","year":"2023","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41467-022-29412-3","article-title":"Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing","volume":"13","author":"Frey","year":"2022","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41467-022-29205-8","article-title":"CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity","volume":"13","author":"Joung","year":"2022","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-0519","article-title":"Epigenetic and transcriptional control of the epidermal growth factor receptor regulates the tumor immune microenvironment in pancreatic cancer","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007891","article-title":"CD58 loss in tumor cells confers functional impairment of CAR T cells","volume":"6","author":"Yan","year":"2022","journal-title":"Blood Adv"},{"key":"B103","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-022-00915-1","article-title":"Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell Malignancies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-2245","article-title":"Systematic interrogation of tumor cell resistance to chimeric antigen receptor T-cell therapy in pancreatic cancer","volume":"83","author":"Hagel","year":"2023","journal-title":"Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004108","article-title":"CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy","volume":"137","author":"Soares","year":"2021","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216780","article-title":"Unlocking c-MET: a comprehensive journey into targeted therapies for breast cancer","volume":"588","author":"Jabbarzadeh Kaboli","year":"2024","journal-title":"Cancer Lett"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf9915","article-title":"Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells","volume":"9","author":"Gu","year":"2023","journal-title":"Sci Adv"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-024752","article-title":"Beyond the barrier: Unraveling the mechanisms of immunotherapy resistance","volume":"42","author":"Bell","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01315-x","article-title":"In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer","volume":"23","author":"Dubrot","year":"2022","journal-title":"Nat Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi9533","article-title":"Loss of TSC1\/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer","volume":"8","author":"Huang","year":"2022","journal-title":"Sci Adv"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-1448","article-title":"CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade","volume":"10","author":"Wang","year":"2020","journal-title":"Cancer Discov"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0780","article-title":"In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Cancer Discov"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","article-title":"TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2139\/ssrn.4270304","article-title":"CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR\/Cas9 screening","volume":"42","author":"Sun","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.02.003","article-title":"Cancer epigenetics, tumor immunity, and immunotherapy","volume":"6","author":"Cao","year":"2020","journal-title":"Trends Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-21-0754","article-title":"The SETDB1-TRIM28 complex suppresses antitumor immunity","volume":"9","author":"Lin","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001819","article-title":"Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators","volume":"9","author":"Hou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/s41467-023-36878-2","article-title":"Checkpoint kinase 1\/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade","volume":"14","author":"Dmello","year":"2023","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1343378","article-title":"Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy","volume":"15","author":"Zarezadeh Mehrabadi","year":"2024","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-156746","article-title":"PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia","volume":"8","author":"Li","year":"2022","journal-title":"Sci Adv"},{"key":"B124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2326-6066.cir-20-0080","article-title":"A CRISPR screen reveals resistance mechanisms to CD3-bispecific antibody therapy","volume":"9","author":"Liu","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.909979","article-title":"CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses","volume":"13","author":"Molony","year":"2022","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004348","article-title":"Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway","volume":"10","author":"Shen","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B127","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/imr.13316","article-title":"Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment","volume":"323","author":"Moinuddin","year":"2024","journal-title":"Immunol Rev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.cell.2021.09.006","article-title":"In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03879-4","article-title":"Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis","volume":"597","author":"Kamber","year":"2021","journal-title":"Nature"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd4742","article-title":"Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation","volume":"7","author":"Tong","year":"2021","journal-title":"Sci Adv"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7554\/elife.65109","article-title":"Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells","volume":"10","author":"Kiritsy","year":"2021","journal-title":"Elife"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.7554\/elife.65110","article-title":"A genetic screen in macrophages identifies new regulators of IFN\u03b3-inducible MHCII that contribute to T cell activation","volume":"10","author":"Kiritsy","year":"2021","journal-title":"Elife"},{"key":"B133","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1038\/s41467-023-41792-8","article-title":"Systematic identification of gene combinations to target in innate immune cells to enhance T cell activation","volume":"14","author":"Xia","year":"2023","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe8219","article-title":"In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response","volume":"6","author":"Sutra Del Galy","year":"2021","journal-title":"Sci Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2018.11.044","article-title":"Genome-wide CRISPR screens in T helper cells reveal pervasive crosstalk between activation and differentiation","volume":"176","author":"Henriksson","year":"2019","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-090222-102834","article-title":"T follicular helper cell heterogeneity","volume":"42","author":"Song","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03692-z","article-title":"Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine","volume":"595","author":"Fu","year":"2021","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41467-022-28378-6","article-title":"In vivo CRISPR screens reveal a HIF-1\u03b1-mTOR-network regulates T follicular helper versus Th1 cells","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00870-6","article-title":"Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine","volume":"21","author":"Kumagai","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2246-4","article-title":"CRISPR screen in regulatory T cells reveals modulators of Foxp3","volume":"582","author":"Cortez","year":"2020","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-22-0606","article-title":"A metabolic gene survey pinpoints fucosylation as a key pathway underlying the suppressive function of regulatory T cells in cancer","volume":"11","author":"Pinioti","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1101\/2021.02.03.428939","article-title":"MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function","volume":"55","author":"Sugiura","year":"2022","journal-title":"Immunity"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01733-5","article-title":"Metabolic waypoints during T cell differentiation","volume":"25","author":"Wilfahrt","year":"2024","journal-title":"Nat Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04109-7","article-title":"CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity","volume":"600","author":"Long","year":"2021","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1182\/blood.2019002121","article-title":"Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity","volume":"135","author":"Dufva","year":"2020","journal-title":"Blood"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0193","article-title":"A high-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of antigen-specific cytotoxic T-lymphocyte tumor cell killing","volume":"6","author":"Lizotte","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B147","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2105-7-216","article-title":"Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114973","article-title":"Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery","volume":"199","author":"Han","year":"2023","journal-title":"Adv Drug Delivery Rev"},{"key":"B151","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat Commun"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004450","article-title":"Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors","volume":"10","author":"Foster","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.1c01532","article-title":"In vitro engineering chimeric antigen receptor macrophages and T cells by lipid nanoparticle-mediated mRNA delivery","volume":"8","author":"Ye","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.1c02503","article-title":"Orthogonal design of experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells","volume":"22","author":"Billingsley","year":"2022","journal-title":"Nano Lett"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:20:58Z","timestamp":1776313258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":155,"alternative-id":["10.3389\/fonc.2026.1787786"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1787786","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1787786"}}